Breaking the silence: Lets talk about inflammatory Bowel Disease and support those affected

  • Hlengiwe Makhubele
  • 24 Jun 2024
  • 625
JOHANNESBURG, June 24th , 2024 ' Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal (GI) tract (1), which will affect the comfort, and therefore quality of life, of patients with the condition. Apart from the pain and ongoing inconvenience experienced by patients, these differences from ones peers could lead to a negative self-perception and fear of ....
Organisation : Janssen Pharmaceutical Companies Of Johnson & Johnson
Tags: #JanssenPharmaceuticalCompaniesOfJohnson&Jphnson